| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |